Keeping healthcare costs under control for consumers is important, but not at the cost of hurting other stakeholders of the industry
Read More
Drug price watchdog, National Pharmaceutical Pricing Authority (NPPA) has fixed or revised retail prices of 37 scheduled formulations
Read More
Thyroid needs early diagnosis and thyroid hormone replacement is a safe and effective treatment that can manage symptoms and prevent complications
Read More
Indian drugmaker Lupin reported its quarterly net profit nearly halved from a year ago, falling far short of analysts' expectations, as sales at its top market the United States slumped while the company's costs jumped
Read More
The current market for plain antihistamines is estimated to be around Rs 860 crore growing at 14 percent during March 2017, according to IMS MAT.
Read More
Dr Reddy's Laboratories Ltd, India's second-largest drugmaker by sales, said it expects no impact from a recent government notice that said the company is selling a high blood pressure drug that lacks the pricing regulator's approval.
Read More
Country’s top drugmakers including Abbott Healthcare, Mankind Pharma, Cadila, Lupin and Biocon are under scanner. NPPA has found around 200 'new drugs' which are either being sold by drug makers without applying for price approvals or have been tweaked to escape the provisions under DPCO
Read More
Backed by its well-known research strength in the natural science and Ayurveda, the company hopes to roll out at least five key drugs to fight out the alarmingly spreading disease
Read More
